Abcellera director Michael R Hayden reports purchase of common shares worth $481,234.19
ABCL•Director reports indirect share purchase
- AbCellera Biologics director Hayden Michael R Hayden reported an indirect purchase of 46,387 common shares at USD 10.37.
- Indirect holdings through Genworks 2 Consulting rose to 1,319,784 common shares.
- A separate indirect position of 118,245 common shares was reported as held by the director’s spouse.
Related News
Nasdaq Trade Halt <KXIN.O> Volatility Trading Pause at 12:31 PM
KXIN•
BRIEF-AB Multi-Manager Alternative Fund To Purchase Up To 10% Of Shares Outstanding As Of August 1, Says SEC Filing
AB•
